RE: share429 May 2020 20:13
"I do think AWS, GCP or Azure will buy companies like DMTR other than pharmas. "
AWS, Azure no.
GCP yes.
"Also to run the tech stack on either cloud with AWS, Azure or GCP i would suggest they would be paying in excess of 200,000 a month at the maturing stage. (2,400,000)"
Again AWS and Azure are a bad fit here. Azure is just not a good choice for this type of stack. AWS will ramp up those costs very quickly.
Maybe excitement are too strong a word, but the point still stands.